Weight Loss Drugs Fuel Investing Opportunities and Boost Apparel Stocks
The increasing popularity of GLP-1 drugs, used to treat diabetes and obesity, has created new investing opportunities. While companies like Eli Lilly and Novo Nordisk, which produce these medications, have already seen significant stock gains, there are other potential winners in this space. Companies known for producing meat and high-protein foods, such as Tyson Foods and Hormel Foods, could benefit as GLP-1 drugs encourage patients to consume more protein. Engineering and construction companies like Jacobs Solutions, which design manufacturing facilities for pharmaceutical companies, may also see gains. Additionally, the apparel industry could benefit as consumers may need new clothes to accommodate their weight loss.